Falk Gastro Info 8/2015

Video

 

 

 

 

 

Video course abdominal ultrasound

Flow pattern of the right liver vein

 

Author: Prof. Dr. Christoph F. Dietrich, Caritas Krankenhaus Bad Mergentheim.

© 2015 Falk Foundation e.V., Freiburg. All rights reserved.

 

 

Please switch on your loudspeakers!

 

 

Link to Falk Mediacenter:

http://media.drfalkpharma.de/index.php?id=127&L=1

 

 

Link to the video directly:

http://media.drfalkpharma.de/fileadmin/media/12_Liver_Flow_pattern_of_the_right_liver_vein_ENG.mp4

 

Preview images:

 

580 x 350 pixels (with arrow)

http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip12_580P.jpg

 

580 x 350 pixels (without arrow)

http://www.drfalkpharma.de/fileadmin/media/newsletter/Logos/Sono_Clip12_580.jpg

 

 

 

 

Bowel

 

 

 

Text:

Monteleone G et al, N Engl J Med. 2015;372(12):1104–13

New therapeutic approach for Crohn’s disease: Mongersen, an oral SMAD7 antisense oligonucleotide, induces clinical remission in > 60% of patients in a phase II trial.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#29244

 

 

 

Text:

Vande Casteele N et al, Gastroenterology. 2015;148(7):1320–9.e3

Continued concentration-based dosing of infliximab is not superior to clinically based dosing for maintaining remission of inflammatory bowel disease.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29245

 

 

 

Text:

Wright EK et al, Gastroenterology. 2015;148(5):938–47.e1

Fecal calprotectin concentrations correlate well with postoperative recurrences of Crohn’s disease.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29246

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liver
Biliary Tracts

 

 

 

Text:

Nelson DR et al, Hepatology. 2015;61(4):1127–35

Hepatitis C: A 12-week course of daclatasvir plus sofosbuvir leads to viral clearance in 96% of patients with genotype 3 infection without cirrhosis.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29247

 

 

 

Text:

Hirschfield GM et al, Gastroenterology. 2015;148(4):751–61.e8

Primary biliary cirrhosis: Obeticholic acid is efficient in patients with prior inadequate response to ursodeoxycholic acid. Pruritus is, however, a principal adverse event.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29248

 

 

 

 

Text:

Schmidt ML et al, Gastroenterology. 2015;148(5):967–77.e2

Liver cirrhosis: Decreasing mortality in the US indicates an improved clinical management of complications of liver cirrhosis. In contrast, the impact of sepsis associated with cirrhosis is growing.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29249

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Oesophagus

Stomach

Duodenum

 

 

Text:

Abraham NS et al, BMJ. 2015;350:h1857

Comparable risk of gastrointestinal bleeding with dabigatran, rivaroxaban and warfarin in a population-based cohort study.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29250

 

 

 

Text:

Bratlie SO et al, Clin Gastroenterol Hepatol. 2015;13(6):1068–74.e2         

Endoscopic surveillance of Barrett’s esophagus: Multiple band imaging is not superior to standard white light endoscopy in the detection of dysplasia, but requires the collection of significantly fewer biopsies.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29251

 

 

Text:

Witteman BPL et al, Am J Gastroenterol. 2015;110(4):531–42

Gastroesophageal reflux disease: Transoral incisionless fundoplication does not result in long-term reflux control.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29252

 

 

Pancreas

 

Text:

Ngamruengphong S et al, Gut. 2015;64(7):1105–10

Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer.

 

Link:

http://www.drfalkpharma.de/index.php?L=1&id=20372#c29253

 

 

 

 

 

Current Falk literature:

 

NEW

The microbiota and intestinal diseases

Authors: B.J. Campbell, J.M. Rhodes

(38 pages)

S19e

 

Picture:

http://www.drfalkpharma.de/fileadmin/media/Falk_Broschueren/Diagnostik_und_Therapie/Titelblatt/S19e_1-2-15.jpg

 

PDF:

http://www.drfalkpharma.de/fileadmin/media/Falk_Broschueren/Diagnostik_und_Therapie/PDF/S19e_1-2-15.pdf